Terms: = Lung cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
50 results:
1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
2. Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell lung cancer from Phase III lung-MAP S1400I Trial.
Parra ER; Zhang J; Duose DY; Gonzalez-Kozlova E; Redman MW; Chen H; Manyam GC; Kumar G; Zhang J; Song X; Lazcano R; Marques-Piubelli ML; Laberiano-Fernandez C; Rojas F; Zhang B; Taing L; Jhaveri A; Geisberg J; Altreuter J; Michor F; Provencher J; Yu J; Cerami E; Moravec R; Kannan K; Luthra R; Alatrash G; Huang HH; Xie H; Patel M; Nie K; Harris J; Argueta K; Lindsay J; Biswas R; Van Nostrand S; Kim-Schulze S; Gray JE; Herbst RS; Wistuba II; Gettinger S; Kelly K; Bazhenova L; Gnjatic S; Lee JJ; Zhang J; Haymaker C
Clin Cancer Res; 2024 Apr; 30(8):1655-1668. PubMed ID: 38277235
[TBL] [Abstract] [Full Text] [Related]
3. A novel transformer-based aggregation model for predicting gene mutations in lung adenocarcinoma.
Sun K; Zheng Y; Yang X; Jia W
Med Biol Eng Comput; 2024 May; 62(5):1427-1440. PubMed ID: 38233683
[TBL] [Abstract] [Full Text] [Related]
4. Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes.
Zhou F; Wang M; Wang Z; Li W; Lu X
BMC Cancer; 2024 Jan; 24(1):28. PubMed ID: 38166691
[TBL] [Abstract] [Full Text] [Related]
5. Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis.
Alfaro-Murillo JA; Townsend JP
Math Biosci; 2023 Dec; 366():109091. PubMed ID: 37996064
[TBL] [Abstract] [Full Text] [Related]
6. Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
Wang H; Yan L; Zhu Y; Sun W; Yang X; Liu X; Chi K; Huang X; Zhou L; Lin D
Hum Pathol; 2023 Dec; 142():81-89. PubMed ID: 37742943
[TBL] [Abstract] [Full Text] [Related]
7.
Feng H; Xu H; Shi X; Ding G; Yan C; Li L; Jian Z; Yang X; Guo H; Li F; Zhang J; Ren X
Front Biosci (Landmark Ed); 2023 Jul; 28(7):147. PubMed ID: 37525904
[TBL] [Abstract] [Full Text] [Related]
8. Gene fusions during the early evolution of mesothelioma correlate with impaired DNA repair and Hippo pathways.
Jama M; Zhang M; Poile C; Nakas A; Sharkey A; Dzialo J; Dawson A; Kutywayo K; Fennell DA; Hollox EJ
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23189. PubMed ID: 37421230
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Mutation Profiling of Colorectal cancer Patients With lung or Liver Metastasis by Targeted Next-Generation Sequencing.
Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
[TBL] [Abstract] [Full Text] [Related]
10. Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort.
Shen F; Guo W; Song X; Wang B
Diagn Pathol; 2023 Jun; 18(1):71. PubMed ID: 37301854
[TBL] [Abstract] [Full Text] [Related]
11. To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations.
Cai R; Zhu H; Liu Y; Sha H; Peng W; Yin R; Zhou G; Fang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10027-10040. PubMed ID: 37261523
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract] [Full Text] [Related]
13. Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.
Goldschmid H; Kluck K; Ball M; Kirchner M; Allgäuer M; Winter H; Herth F; Heußel CP; Pullamsetti SS; Savai R; Yong TTK; Schirmacher P; Peters S; Thomas M; Christopoulos P; Budczies J; Stenzinger A; Kazdal D
Lung Cancer; 2023 Jun; 180():107212. PubMed ID: 37141769
[TBL] [Abstract] [Full Text] [Related]
14. Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor.
Lin Y; Yu B; Sun H; Zhang H; Hu Z; Zhang Y; Wu Z; Sun S; Zhao X; Yu H; Wu X; Li Y; Wang J; Wang H
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8663-8671. PubMed ID: 37115272
[TBL] [Abstract] [Full Text] [Related]
15. Mutant-allele dispersion correlates with prognosis risk in patients with advanced non-small cell lung cancer.
Wang CX; Yan J; Lin S; Ding Y; Qin YR
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8545-8555. PubMed ID: 37093348
[TBL] [Abstract] [Full Text] [Related]
16. Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma.
Rao W; Yang L; Dai N; Zhang L; Liu J; Yang B; Li M; Shan J; Wang Q; Wang D
Clin Transl Oncol; 2023 Jun; 25(6):1767-1778. PubMed ID: 36739576
[TBL] [Abstract] [Full Text] [Related]
17. Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell lung cancer.
Liao R; Chen K; Li J; He H; Yi G; Huang M; Chen R; Shen L; Zhang X; Xu Z; Yang Z; Peng Y
Cancer Res Treat; 2023 Jul; 55(3):814-831. PubMed ID: 36634615
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
[TBL] [Abstract] [Full Text] [Related]
19. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
20. Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.
Zhou J; Bao M; Gao G; Cai Y; Wu L; Lei L; Zhao J; Ji X; Huang Y; Su C
BMC Med; 2022 Jul; 20(1):256. PubMed ID: 35902848
[TBL] [Abstract] [Full Text] [Related]
[Next]
